Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
OLMESARTAN HCT MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack, Merck Sharp Dohme (Australia) Pty Ltd, CON-623
Product name
OLMESARTAN HCT MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack
Sponsor name
Merck Sharp Dohme (Australia) Pty Ltd
Consent start
Consent no.
CON-623
Standard
Sections 9(3a) and 9(5) of the Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The size and layout of the active ingredient and strength information does not
comply with TGO 91 and a commitment to lodge a variation request to address this
matter has been made.
Therapeutic product type
Prescription medicines